Sales and earnings (Q4 2022)

Net revenue
497,4 MSEK (+95%)
Op. EBITDA
120,2 MSEK (+149%)
All key figures

Financial reports

Yearend report
Q4 2022
Interim Report
Q3 2022
Half Year Report
Q2 2022
Interim Report
Q1 2022
All reports

Calendar

March 30
Swiss Nordic Bio 2023 (Zürich, Switzerland)
April 6
Annual Report 2022
April 28
Interim Report Q1 2023
Calendar

Pressreleases & news

Swedencare AB (publ) YEAREND REPORT January 1 – December 31, 2022
16 FEBRUARY 2023 08:00
Employees in the Swedencare Group acquire warrants
DECEMBER 12 2022 10:30
Swedencare AB (publ) Nomination Committee for the 2023 Annual General Meeting
NOVEMBER 30 2022 1:45
Pressreleases and news

Latest presentations

Swedencare Q4 2022 Webinar (video)
FEBRUARY 16
Swedencare Q3 2022 Webinar (video)
OCTOBER 27 2022
Swedencare Q2 2022 Webinar (video)
JULY 28 2022
Swedencare Q2 2022 Webinar (PDF)
JULY 28 2022
Latest presentations

  • Investor contact

    If you have any questions or concerns- please do not hesitate to contact us!

    info@swedencare.se +46 (0)40-859 33

    • Presentation of Q4 2022

    ”Improved profitability but not expected growth numbers. With yet another acquisition in the last quarter we have added three new members to the Swedencare family during 2022. The net revenue for the 4th quarter was 497 MSEK, which is an increase of 95% compared to Q4 2021 and it makes it our strongest quarter ever.” – Håkan Lagerberg, CEO

    CEO Håkan Lagerberg